Evidence map›Paper›PMID 24672638›Full record

ArticleOxidative medicine and cellular longevity2014

On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes.

Radomír Nosáľ, Katarína Drábiková, Viera Jančinová, Tomáš Perečko, Gabriela Ambrožová, Milan Číž, Antonín Lojek, Michaela Pekarová, Jan Šmidrkal, Juraj Harmatha

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Resveratrol as a Regulator of Inflammation, Oxidative Stress, and Glucose Stability in Diabetes.Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Biogenesis of Iron-Sulfur Clusters and Their Role in DNA Metabolism.Frontiers in cell and developmental biology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Radomír NosáľInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
Katarína DrábikováInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
Viera JančinováInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
Tomáš PerečkoInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia.
Gabriela AmbrožováInstitute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
Milan ČížInstitute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
Antonín LojekInstitute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
Michaela PekarováInstitute of Biophysics AS CR v.v.i. Královopolská 135, 612 65 Brno, Czech Republic.
Jan ŠmidrkalInstitute of Chemical Technology, Faculty of Food and Biochemical Technology, Technická 5, 166 28 Praha 6, Czech Republic.
Juraj HarmathaInstitute of Organic Chemistry and Biochemistry AS CR v.v.i., Flemmingovo nám. 2, 166 10 Praha 6, Czech Republic.
Czech Academy of Sciences, Institute of Biophysics · CZInstitute of Experimental Pharmacology and Toxicology of the Slovak Academy of Sciences · SKSlovak Academy of Sciences · SKCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZUniversity of Chemistry and Technology, Prague · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol-3,5,4'-trihydroxystilbene-possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 μM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 μM significantly decreased PMA-induced phosphorylation of PKC α/β II. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.

Indexed as

AnimalsCell LineCell SeparationCell SurvivalFree Radical ScavengersHumansLipid PeroxidationLuminescent MeasurementsLuminolMiceNeutrophilsNitric Oxide Synthase Type IINitritesPhagocytesProtein KinasesReactive Oxygen SpeciesFree Radical ScavengersLuminolNitric Oxide Synthase Type IINitritesProtein KinasesReactive Oxygen SpeciesResveratrolStilbenesTetradecanoylphorbol AcetateThiobarbituric Acid Reactive Substances

Identifiers

PMID24672638
PMCPMC3942095
OpenAlexW1977322506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.